Lucozade, Ribena sale
British pharmaceuticals giant GlaxoSmithKline is to sell drinks brands Lucozade and Ribena, which could fetch more than £1 billion ($1.48 billion).
British pharmaceuticals giant GlaxoSmithKline is to sell drinks brands Lucozade and Ribena, which could fetch more than £1 billion ($1.48 billion).
Want access to our latest research and new buy ideas?
Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.
Sign up for free